← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2000Last known activity
Jan 1, 2011
Timeline
1980s
- Jun 1, 1984
Amarillo Biosciences, Inc.— Founded
Drugs by trial phase (3 distinct, 7 trials)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Behcet Syndrome
- Cough
- Fibrosis
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Idiopathic Pulmonary Fibrosis
- Infections
- Influenza, Human
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Papilloma
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Respiratory Tract Diseases
- Respiratory Tract Infections
- Virus Diseases
Recent trials (7)
- NCT01146535Lead sponsorPhase 2Jan 1, 2011
- NCT00695019Lead sponsorPhase 2Jun 1, 2009
- NCT00895947Lead sponsorPhase 2Apr 1, 2009
- NCT00690885Lead sponsorPhase 2Jun 1, 2008
- NCT00454181Lead sponsorPhase 2Feb 1, 2007
- NCT00483184CollaboratorPhase 2Apr 1, 2006
- NCT01442779CollaboratorPhase 2Sep 1, 2000
Details
- Founded
- Amarillo, TX, US Jun 1, 1984
- Last known activity
- Jan 1, 2011